Study finds Vimpat 'significantly' reduces partial-onset seizures Bayer receives orphan drug designation for CF treatment FDA accepts approval application for lurasidone Decision Resources: Acute migraine therapy designed for vascular disease patients will capture market share FDA committee recommends approval for InterMune’s Esbriet Abbott to boost business with Facet acquisition Roche, Biogen Idec halt ocrelizumab trials Bristol-Myers Squibb, Isis announce partnership for cholesterol drug Clinical study: Pfizer-Bristol anticoagulant more effective than competitior Genzyme, PTC: Mid-stage trial for DBMD treatment yields mixed results First Previous 207 208 209 210 211 Next Last
